Nutritional intervention with cyanidin hinders the progression of muscular dystrophy.
Marielle SaclierChiara BonfantiStefania AntoniniGiuseppe AngeliniGiada MuraFederica ZanaglioValentina TagliettiVanina RomanelloMarco SandriChiara TonelliKatia PetroniMarco CassanoGraziella MessinaPublished in: Cell death & disease (2020)
Muscular Dystrophies are severe genetic diseases due to mutations in structural genes, characterized by progressive muscle wasting that compromises patients' mobility and respiratory functions. Literature underlined oxidative stress and inflammation as key drivers of these pathologies. Interestingly among different myofiber classes, type I fibers display a milder dystrophic phenotype showing increased oxidative metabolism. This work shows the benefits of a cyanidin-enriched diet, that promotes muscle fiber-type switch and reduced inflammation in dystrophic alpha-sarcoglyan (Sgca) null mice having, as a net outcome, morphological and functional rescue. Notably, this benefit is achieved also when the diet is administered in dystrophic animals when the signs of the disease are seriously evident. Our work provides compelling evidence that a cyanidin-rich diet strongly delays the progression of muscular dystrophies, paving the way for a combinatorial approach where nutritional-based reduction of muscle inflammation and oxidative stress facilitate the successful perspectives of definitive treatments.
Keyphrases
- oxidative stress
- muscular dystrophy
- skeletal muscle
- weight loss
- physical activity
- diabetic rats
- end stage renal disease
- dna damage
- ischemia reperfusion injury
- induced apoptosis
- randomized controlled trial
- ejection fraction
- genome wide
- chronic kidney disease
- newly diagnosed
- systematic review
- resistance training
- peritoneal dialysis
- prognostic factors
- early onset
- duchenne muscular dystrophy
- type diabetes
- radiation therapy
- locally advanced
- body composition
- patient reported outcomes
- dna methylation
- high intensity
- transcription factor